BUFFALO, N.Y. -- Eugene D. Morse, PharmD, professor of pharmacy
practice and associate director of the Translational Pharmacology
Core in the University at Buffalo Center of Excellence in
Bioinformatics and Life Sciences, has been honored with this year's
Volwiler Research Achievement Award from the American Association
of Colleges of Pharmacy (AACP) for outstanding research and
contributions to the fields of clinical/translational pharmacology
and pharmaceutical sciences.
It is only the second time in the award's history that the honor
has been bestowed on a clinical scientist.
The Volwiler Research Achievement Award consists of a gold medal
and a monetary prize and was established in honor of the late
Ernest H. Volwiler, Abbott Laboratories former president and
Morse received the prestigious award during the AACP Annual
Meeting, Pharmacy Education 2012, in Kissimmee, Fla.
"Receiving the Volwiler Award from AACP is a great honor," Morse
said. "I am proud to be a part of the innovative research conducted
by AACP faculty throughout the country and to contribute to
mentoring future researchers with an interest in clinical research
and pharmaceutical sciences.
"The field of translational pharmacology is growing rapidly and
current students, residents and fellows have a great opportunity to
contribute to the field of biomedical research using the
outstanding training they receive from AACP member institutions and
Morse has distinguished himself as a pioneer in AIDS clinical
Over the past 25 years, Morse's cutting-edge research in
HIV/AIDS has received grant funding of $25.8 million as a primary
investigator and $3.8 million as a co-investigator.
In 1986 he was one of the first investigators selected to be
part of the NIH-sponsored AIDS Clinical Trials Group (ACTG) and one
of the first HIV Clinical Pharmacology Specialty Laboratories in
the United States.
The UB HIV Clinical Pharmacology Laboratory was a leader in
introducing therapeutic drug monitoring (TDM) in ACTG research
protocols and TDM and pharmacogenomics within studies of
HIV-infected patients with substance-related disorders.
"Gene has taken results from the laboratory to the clinic in a
complex translational research environment," said Wayne K.
Anderson, PhD, dean of the UB School of Pharmacy and Pharmaceutical
Sciences. "His research along with his passion for clinical
pharmacy has made a difference to millions of individuals with
During the early period of the HIV epidemic, Morse established
the Adherence-Pharmacology Unit at the Erie County Medical Center
to provide an interface between clinical practice and research.
Subsequently, Morse established the National HIV TDM Registry
for protease inhibitors, providing a mechanism for clinical sites
around the United States to participate in a population-based
research project to facilitate patient management through a
centralized clinical pharmacology resource.
In addition to his HIV clinical pharmacology research, Morse is
actively involved in teaching and mentoring.
He was the chair of pharmacy practice during the university's
transition from a bachelor of science degree to the PharmD. The new
curriculum was developed to include both a clinical and a
pharmaceutical sciences research track, which now involves 10 to 20
students per year.
Morse also worked with colleagues to implement the UB Pharmacy
Practice Residency Program, with both PGY1 and PGY2 residency
programs. They serve as important components of the portfolio of
academic and clinical research programs offered at UB.
As the HIV/AIDS epidemic expanded and the applied therapeutics
field became more complex, Morse created opportunities for graduate
pharmacists who were interested in gaining more expertise in this
area. These programs include an HIV Certification Program, a PGY2
HIV/Infectious Diseases Residency and an HIV Clinical Pharmacology
In 2009 he received an NIH Fogarty International Center AIDS
International Training and Research Program (AITRP) Award. The
program consists of a partnership with the University of Zimbabwe
and establishes an international HIV Clinical Pharmacology
Fellowship program. This award has energized the faculty and
students at the University of Zimbabwe and has become a centerpiece
for capacity building in the region.
In his role in UB's Center of Excellence in Bioinformatics and
Life Sciences, Morse is working to bridge the HIV/AIDS clinical and
research experience with resource-limited countries through
"Dr. Morse's work has changed the landscape of treatment for
patients with HIV/AIDS both here and around the world," said
Lucinda L. Maine, PhD, RPh, AACP executive vice president and CEO.
"We are so pleased to honor him with the 2012 Volwiler Research